Evidence map›Paper›PMID 34981473›Full record

ArticleAdvances in experimental medicine and biology2021

Antiviral Plants in View of Avicenna's The Canon of Medicine and Modern Medicine Against Common Cold.

Elham Ramazani, Seyed Ahmad Emami, Nilufar Tayarani-Najaran, Amirhossein Sahebkar, Zahra Tayarani-Najaran

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. The effect ofFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elham RamazaniMedical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Seyed Ahmad EmamiDepartment of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Nilufar Tayarani-NajaranDepartment of Prosthodontics, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
Amirhossein SahebkarApplied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra Tayarani-NajaranTargeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. tayaraninz@mums.ac.ir.
Mashhad University of Medical Sciences · IRKosar University of Bojnord · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common cold is known as a serious clinical problem worldwide. Coronaviruses have long been identified as respiratory pathogens causing "common cold" in healthy people. The pandemic of 2019 novel coronavirus as a serious public health problem and concern has resulted in severe illness and death especially in the elderly. COVID-19 is picking up pace around the world and has spread to more than 219 countries. Due to the very easy spread of COVID-19 and its lack of recognized appropriate treatments and vaccines as well as potential therapeutic effects of several traditional herbal remedies, we decided to gather, evaluate, and compare the potential pharmacological effects of medicinal herbs from Avicenna's perspective and modern medicine with antiviral properties which may lead to the discovery of suitable traditional treatments to prevent or reduce the adverse symptoms of common cold.

Indexed as

Common ColdCOVID-19AgedAntiviral AgentsHumansPublic HealthSARS-CoV-2Antiviral AgentsAntiviralAvicennaCommon coldCoronavirusCOVID-19Medicinal plants

Identifiers

PMID34981473
OpenAlexW4206209667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.